Heron Therapeutics reported $-60469000 in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Amarin AMRN:US 8.77M 10.1M
Ani Pharmaceuticals ANIP:US $ -6638000 9.72M
Anika Therapeutics ANIK:US $ -2262000 1.28M
Arrowhead Research ARWR:US $ -31868000 3.64M
Eisai 4523:JP 55.41B 61.33B
Emergent Biosolutions EBS:US $ 14.5M 80.9M
Endo International Ordinary Shares ENDP:US $ 195.54M 19.6M
Esperion Therapeutics ESPR:US $ -32533000 50.29M
Flexion Therapeutics FLXN:US $ -16882000 6.26M
GlaxoSmithKline GSK:LN 1.96B 281M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Heron Therapeutics HRTX:US $ -60469000 8.36M
Immunogen IMGN:US $ -27369000 1.55M
Insmed INSM:US $ -88566000 4.73M
JAZZ PHA JAZZ:US -69590000 231.71M
Ligand Pharmaceuticals LGND:US $ 45.76M 41.04M
Merk MRK:US $ 3930M 332M
Nektar Therapeutics NKTR:US $ -110205000 813K
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Omeros OMER:US $ -24016000 6.6M
Pacira Pharmaceuticals PCRX:US $ 34.99M 13.68M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sangamo Biosciences SGMO:US $ -48700000 2.4M
Surmodics SRDX:US $ -1923000 11.41M
Teva Pharmaceutical Industries TEVA:US 829M 35M
Ultragenyx Pharmaceutical RARE:US $ -82776000 23.79M
Veracyte VCYT:US $ 1.23M 11.54M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M
Zogenix ZGNX:US $ -55431000 3.63M